Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013 (2013), Article ID 240659, 5 pages
http://dx.doi.org/10.1155/2013/240659
Research Article

Ultrastructural Study of Alveolar Epithelial Type II Cells by High-Frequency Oscillatory Ventilation

Department of Pediatrics, Guangdong Second Provincial People’s Hospital, No. 1 Shiliugang Road, Haizhu District, Guangzhou 510317, China

Received 13 August 2013; Accepted 17 November 2013

Academic Editor: Demosthenes Bouros

Copyright © 2013 Xiaofei Qin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L.-H. Shu, K.-L. Wei, Y.-X. Shang et al., “Relationship between alveolar epithelial type II cells and pulmonary surfactant protein A levels in young rats with acute lung injury,” Chinese Journal of Contemporary Pediatrics, vol. 10, no. 4, pp. 504–508, 2008. View at Google Scholar · View at Scopus
  2. L.-H. Shu, K.-L. Wei, C.-F. Liu et al., “Changes of pulmonary surfactant protein A in young rats with acute lung injury induced by lipopolysaccharide,” Chinese Journal of Contemporary Pediatrics, vol. 10, no. 2, pp. 203–206, 2008. View at Google Scholar · View at Scopus
  3. J. Pugin, I. Dunn, P. Jolliet et al., “Activation of human macrophages by mechanical ventilation in vitro,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 275, no. 6, part 1, pp. L1040–L1050, 1998. View at Google Scholar · View at Scopus
  4. N. E. Vlahakis, M. A. Schroeder, A. H. Limper, and R. D. Hubmayr, “Stretch induces cytokine release by alveolar epithelial cells in vitro,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 277, no. 1, part 1, pp. L167–L173, 1999. View at Google Scholar · View at Scopus
  5. T. J. Gregory, W. J. Longmore, M. A. Moxley et al., “Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome,” Journal of Clinical Investigation, vol. 88, no. 6, pp. 1976–1981, 1991. View at Google Scholar · View at Scopus
  6. U. Pison, U. Obertacke, M. Brand et al., “Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure,” Journal of Trauma, vol. 30, no. 1, pp. 19–26, 1990. View at Google Scholar · View at Scopus
  7. A. Günther, C. Siebert, R. Schmidt et al., “Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 1, pp. 176–184, 1996. View at Google Scholar · View at Scopus
  8. D. Vockeroth, L. Gunasekara, M. Amrein, F. Possmayer, J. F. Lewis, and R. A. W. Veldhuizen, “Role of cholesterol in the biophysical dysfunction of surfactant in ventilator-induced lung injury,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 298, no. 1, pp. L117–L125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. W. H. Fu, X. F. Qin, C. M. You et al., “High frequency oscillatory ventilation versus conventional ventilation in a newborn piglet model with acute lung injury,” Respir Care, vol. 58, no. 5, pp. 824–830, 2013. View at Google Scholar
  10. A. J. Thorley, P. Goldstraw, A. Young, and T. D. Tetley, “Primary human alveolar type II epithelial cell CCL20 (macrophage inflammatory protem-3α)-induced dendritic cell migration,” American Journal of Respiratory Cell and Molecular Biology, vol. 32, no. 4, pp. 262–267, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Sato, H. Tomioka, T. Shimizu, T. Gonda, F. Ota, and C. Sano, “Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines,” Journal of Infectious Diseases, vol. 185, no. 8, pp. 1139–1147, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Kannan, H. Huang, D. Seeger et al., “Alveolar epithelial type II cells activate alveolar macrophages and mitigate P. aeruginosa infection,” PLoS ONE, vol. 4, no. 3, Article ID e4891, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. V. A. Fadok, D. L. Bratton, A. Konowal, P. W. Freed, J. Y. Westcott, and P. M. Henson, “Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF,” Journal of Clinical Investigation, vol. 101, no. 4, pp. 890–898, 1998. View at Google Scholar · View at Scopus
  14. M.-L. N. Huynh, V. A. Fadok, and P. M. Henson, “Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation,” Journal of Clinical Investigation, vol. 109, no. 1, pp. 41–50, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Teder, R. W. Vandivier, D. Jiang et al., “Resolution of lung inflammation by CD44,” Science, vol. 296, no. 5565, pp. 155–158, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. S. P. Hart, G. J. Dougherty, C. Haslett, and I. Dransfield, “CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages,” Journal of Immunology, vol. 159, no. 2, pp. 919–925, 1997. View at Google Scholar · View at Scopus
  17. E. Crouch and J. R. Wright, “Surfactant proteins A and D and pulmonary host defense,” Annual Review of Physiology, vol. 63, pp. 521–554, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. J. R. Wright, “Clearance and recycling of pulmonary surfactant,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 259, no. 2, part 1, pp. L1–L12, 1990. View at Google Scholar · View at Scopus
  19. O. A. Quintero and J. R. Wright, “Clearance of surfactant lipids by neutrophils and macrophages isolated from the acutely inflamed lung,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 282, no. 2, pp. L330–L339, 2002. View at Google Scholar · View at Scopus
  20. W. J. Piotrowski and J. Marczak, “Cellular sources of oxidants in the lung,” International Journal of Occupational Medicine and Environmental Health, vol. 13, no. 4, pp. 369–385, 2000. View at Google Scholar · View at Scopus
  21. S. Andersson, A. Kheiter, and T. A. Merritt, “Oxidative inactivation of surfactants,” Lung, vol. 177, no. 3, pp. 179–189, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. J. L. Malloy and J. R. Wright, “In vivo clearance of surfactant lipids during acute pulmonary inflammation,” Respiratory Research, vol. 5, article 8, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. J. R. Wright, “Host defense functions of pulmonary surfactant,” Biology of the Neonate, vol. 85, no. 4, pp. 326–332, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Stüber, H. Wrigge, S. Schroeder et al., “Kinetic and reversibility of mechanical ventilation-associated pulmonary and systemic inflammatory response in patients with acute lung injury,” Intensive Care Medicine, vol. 28, no. 7, pp. 834–841, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. P. E. Parsons, M. A. Matthay, L. B. Ware, and M. D. Eisner, “Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 288, no. 3, pp. L426–L431, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. P. E. Parsons, M. D. Eisner, B. T. Thompson et al., “Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury,” Critical Care Medicine, vol. 33, no. 1, pp. 1–6, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Cepkova, S. Brady, A. Sapru, M. A. Matthay, and G. Church, “Biological markers of lung injury before and after the institution of positive pressure ventilation in patients with acute lung injury,” Critical Care, vol. 10, no. 5, article R126, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. M. D. Eisner, P. Parsons, M. A. Matthay, L. Ware, and K. Greene, “Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury,” Thorax, vol. 58, no. 11, pp. 983–988, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. R. M. Determann, A. A. N. M. Royakkers, J. J. Haitsma et al., “Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients,” BMC Pulmonary Medicine, vol. 10, article 6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Capoluongo, G. Vento, C. Santonocito et al., “Comparison of serum levels of seven cytokines in premature newborns undergoing different ventilatory procedures: high frequence oscillatory ventilation or synchronized intermittent mandatory ventilation,” European Cytokine Network, vol. 16, no. 3, pp. 199–205, 2005. View at Google Scholar · View at Scopus
  31. K. von der Hardt, M. A. Kandler, L. Fink et al., “High frequency oscillatory ventilation suppresses inflammatory response in lung tissue and microdissected alveolar macrophages in surfactant depleted piglets,” Pediatric Research, vol. 55, no. 2, pp. 339–346, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. B. A. Yoder, T. Siler-Khodr, V. T. Winter, and J. J. Coalson, “High-frequency oscillatory ventilation: effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 5, pp. 1867–1876, 2000. View at Google Scholar · View at Scopus